No category found.

  • To immediately declare the drug unsafe.
  • To rapidly analyze the data for patterns and statistical significance, to inform immediate public health action.
  • To wait for more data to accumulate.
  • To disregard the reports as anecdotal.
  • To immediately recommend approval.
  • To caution that a non-significant result might be due to low power (Type II error) rather than true ineffectiveness, necessitating further investigation.
  • To ignore the power and focus on the p-value.
  • To recommend disapproval regardless of findings.
Scroll to Top